Clin Chim Acta 164:261266 Invernizzi F, Burlina AB, Donadio A, Giordano G, Taroni F, Garavaglia B (2001) Lethal neonatal presentation of carnitine palmitoyltransferase I deficiency
The "bpc 157 vs tb 500" question rarely has a single answer in research terms, because the two are typically studied for different mechanistic questions
Common side effects include nausea (affecting 20-40% of patients, particularly during dose initiation), constipation, diarrhea or loose stools, abdominal discomfort or cramping, decreased appetite beyond desired levels, fatigue or reduced energy, and headaches
doi:10.1056/NEJMoa2403347 Nissen SE, Nicholls SJ, Sipahi I, et al